.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Details for Patent: 5,957,886

« Back to Dashboard
Patent 5,957,886 protects SUMAVEL DOSEPRO and is included in one NDA. There is one tentative approval for the compound protected by this patent. Additional details are available via the generic ingredient links below.

This patent has eighteen patent family members in seventeen countries.

Summary for Patent: 5,957,886

Title: Spring-Powered dispensing device
Abstract:A needleless injector is described for dispensing a liquid material, comprising a dispensing member which moves under the force of a spring providing an energy store. A damping arrangement, employing a viscous damping medium such as grease, is used to damp recoil during dispensing.
Inventor(s): Weston; Terence Edward (Suffolk, GB)
Assignee: Weston Medical Limited (Suffolk, GB)
Application Number:08/913,254
Patent Claim Types:
see list of patent claims
Dosage form;
Patent Metrics:
Source: PatentQuant.com
Field: Medical technology
Back Citations: 12th percentile
Forward Citations: 8th percentile

Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Endo Ventures Ltd
SUMAVEL DOSEPRO
sumatriptan succinate
INJECTABLE;SUBCUTANEOUS022239-001Jul 15, 2009RXYes5,957,886► subscribeY
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Foreign Priority and PCT Information for Patent: 5,957,886

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom9504878Mar 10, 1995
PCT Information
PCT FiledMarch 08, 1996PCT Application Number:PCT/GB96/00551
PCT Publication Date:September 19, 1996PCT Publication Number: WO96/28202

International Patent Family for Patent: 5,957,886

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria204771► subscribe
Australia4949896► subscribe
Brazil9607219► subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc